Article Details

Morphic partners with investor AbbVie on integrin inhibitor development

Retrieved on: 2018-10-18 00:52:30

Tags for this article:

Click the tags to see associated articles and topics

Morphic partners with investor AbbVie on integrin inhibitor development. View article details on hiswai:

Excerpt

<div>Participants in the $51.5 million Series A round included AbbVie Ventures, Omega Funds and founding investors <b>Polaris Partners</b>, ShangPharma ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up